Q1 2022 13F Holders as of 3/31/2022
-
Type / Class
-
Equity / Common Shares, $0.001 par value
-
Shares outstanding
-
104M
-
Number of holders
-
65
-
Total 13F shares, excl. options
-
20.2M
-
Shares change
-
+1.82M
-
Total reported value, excl. options
-
$406M
-
Value change
-
+$35.6M
-
Number of buys
-
44
-
Number of sells
-
-30
-
Price
-
$20.06
Significant Holders of BlackRock Health Sciences Term Trust - Common Shares, $0.001 par value (BMEZ) as of Q1 2022
83 filings reported holding BMEZ - BlackRock Health Sciences Term Trust - Common Shares, $0.001 par value as of Q1 2022.
BlackRock Health Sciences Term Trust - Common Shares, $0.001 par value (BMEZ) has 65 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 20.2M shares
of 104M outstanding shares and own 19.49% of the company stock.
Largest 10 shareholders include MORGAN STANLEY (6.61M shares), UBS Group AG (3.76M shares), BANK OF AMERICA CORP /DE/ (3.05M shares), WELLS FARGO & COMPANY/MN (1.28M shares), RAYMOND JAMES & ASSOCIATES (1.04M shares), Cornerstone Advisors, LLC (501K shares), 1607 Capital Partners, LLC (358K shares), STIFEL FINANCIAL CORP (268K shares), WOLVERINE ASSET MANAGEMENT LLC (261K shares), and CITY OF LONDON INVESTMENT MANAGEMENT CO LTD (218K shares).
This table shows the top 65 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.